Product Name: LL-37
Specification: 5mg/vial
Purity: ≥ 99%
Form: Lyophilized powder
Storage: Store at -20°C in a cool, dry environment
👥 Target Users:
✔️ Fitness and body transformation specialists
✔️ Wellness and anti-aging centers
✔️ Aesthetic medical clinics and beauty hospitals
✔️ Peptide sourcing agents and global resellers
✔️ Laboratories focused on body regulation studies
LL‑37 is a cationic antimicrobial peptide (AMP) and the only member of the human cathelicidin family. It’s derived from a larger precursor protein called hCAP18, and it plays a pivotal role in innate immune defense by fighting off bacterial, viral, and fungal infections.
LL‑37 is produced naturally by immune cells, epithelial cells, and bone marrow-derived cells in response to infection or tissue injury. It acts as both an antimicrobial agent and a signaling molecule that regulates inflammation, tissue repair, and immune response.
Broad-spectrum antimicrobial action (kills bacteria, viruses, fungi)
Promotes wound healing and epithelial cell migration
Regulates inflammatory responses by modulating cytokines
Supports tissue regeneration and immune system priming
Found naturally in skin, lungs, gastrointestinal tract, and bone marrow
Unlike other therapeutic peptides, LL‑37 doesn’t target muscle growth or hormonal function. Instead, it enhances recovery and resilience by modulating the body’s immune and healing mechanisms—making it particularly useful in infection-prone or inflammation-heavy conditions.
Unlike performance peptides that focus on muscle growth or hormonal balance, LL‑37 shines in areas of immune function, infection control, and tissue recovery. Its versatility makes it appealing for athletes, biohackers, and individuals with chronic inflammation or persistent injuries.
Antibacterial, Antiviral, and Antifungal Defense
LL‑37 has potent broad-spectrum antimicrobial effects. It can neutralize a wide range of pathogens, including gram-positive and gram-negative bacteria, fungi, and enveloped viruses like influenza and herpes.
Active against Staphylococcus aureus, E. coli, Pseudomonas, Candida, and MRSA
Useful in skin infections, wound healing, and respiratory tract infections
May reduce frequency and severity of cold and flu-like illnesses
LL‑37 promotes rapid healing of cuts, abrasions, ulcers, and burns by stimulating cell migration, collagen synthesis, and angiogenesis.
Useful for acne scars, diabetic ulcers, or post-surgical wounds
May support dermatological recovery from eczema or psoriasis
Enhances fibroblast function and tissue strength in healing phases
Gut Health and Inflammation Control
LL‑37 is expressed in the gastrointestinal tract, where it defends against pathogenic bacteria and supports epithelial integrity. It may help in conditions like leaky gut, IBD, or chronic bloating.
Reduces intestinal inflammation
Supports gut lining repair and mucosal immune defense
Often stacked with BPC‑157 for synergistic GI recovery
LL‑37 plays a dual role in stimulating the immune system and reducing unnecessary inflammation, depending on what's needed. It may enhance overall immune readiness, especially during periods of stress, travel, or illness.
Balances immune responses without overstimulation
May reduce chronic inflammation in autoimmune conditions
Supports recovery from upper respiratory and GI infections
LL‑37 exerts its effects through multiple physiological pathways, targeting both pathogen elimination and tissue regeneration. Its actions are localized and systemic, meaning it can be effective whether used for skin wounds, gut health, or internal immune support.
LL‑37 disrupts the cell membranes of bacteria, viruses, and fungi, leading to microbial death. Unlike traditional antibiotics, LL‑37 is less prone to resistance due to its broad, non-specific mechanism.
Inserts into microbial membranes and forms pores
Causes lysis of bacterial or fungal cells
Effective against antibiotic-resistant strains like MRSA
LL‑37 helps regulate the inflammatory cascade, acting as a chemoattractant for immune cells (like neutrophils and macrophages) and modulating cytokine release. It can either promote or suppress inflammation depending on the local environment.
Stimulates immune cells at injury or infection sites
Reduces pro-inflammatory cytokines (e.g., TNF‑α, IL‑6) in chronic inflammation
Enhances production of anti-inflammatory mediators
LL‑37 supports epithelial cell proliferation, angiogenesis (new blood vessel formation), and extracellular matrix remodeling, accelerating the healing of skin, mucosal surfaces, and even GI tissues.
Promotes keratinocyte and fibroblast migration
Enhances collagen deposition and tissue strength
Speeds recovery in skin wounds, ulcers, and gut lining damage
Gut Disruption at High Doses
Overstimulation in Autoimmune Conditions
Flu-like Symptoms or Systemic Inflammation
Injection site irritation (swelling, redness, or discomfort)
Educational guide for reconstitution and weekly dosing